For instance, SCFAs enhance CD8+ T cell activation in colorectal cancer (CRC), particularly in microsatellite instability CRCs, which are more sensitive to SCFA treatment than chromosomally unstable CRCs. This evidence concerns the gene CD8A and colorectal carcinoma.